Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Myofibroma × Tranexamic Acid × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Hemorrhage 5 Hematologic Neoplasms 3 Head and Neck Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Postoperative Complications 1 Myofibroma 1 Metrorrhagia 1 Meningioma 1 Melanoma 1 Leiomyoma 1 Glioma 1 Astrocytoma 1

Interventions

relugolix 2 Misoprostol 2 ramosetron 1 estradiol, norethindrone drug combination 1 Tranexamic Acid 1 Saline Solution 1 Dinoprostone 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04311073 2023-09-11

Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Eastern Virginia Medical School

Phase 3 Unknown

Leiomyoma, Metrorrhagia, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡